about
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Nutritional status at the moment of diagnosis in childhood cancer patients.L-thyroxine therapy and growth processes in children with Down syndrome.A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.Blood mRNA Measurement (NETest) for Neuroendocrine Tumors diagnosis of Image-negative liver metastatic diseaseSurgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or MoreMolecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsyCaveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of PrometheusThe NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine TumorsMeasurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumorsBlood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive DiseaseAn Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-AnalysisCirculating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical ResectionUtility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
P50
Q33656484-0E49C5F3-7454-4584-9C90-F1C7F891DDCCQ50089865-417F0F9B-73B8-4CA3-A869-363F5B9A0BCAQ51208232-F3F72FC6-E8E8-4426-B8C9-770BD6ABB4B6Q52642551-24F960B4-5A24-4536-B78B-0C6AFCD7F120Q53077050-94D643B4-F414-4CB4-8C61-40AE8C333982Q57792187-F2C9A21B-C2E5-45F9-B236-DA7F361DFCE1Q88369771-D19E162D-9550-41D6-A0A8-F986D19A85CDQ89669038-22251C9C-DFD8-4EFF-88C8-CCDBABEF9A1DQ90853520-9A1A1928-B33A-42A4-B540-AF5D3CC73220Q90891558-B98B6782-8D5B-40AB-8C91-087A8DC331B3Q90980271-3F619E68-8F13-4974-992B-253BAB22DC27Q91013316-3F5A1178-4A36-429A-BB4C-B8C11582CDD6Q91093096-219107AD-C7D6-4C86-82F0-3CA8EA9D6AA6Q91557220-A5309761-BE9A-425C-B56A-555865F073B0Q92367128-99BD3C2B-7178-4994-B2B5-51DE11425DAEQ93075744-162EA89E-4E38-43A3-A517-3B3D7A5ED31E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Anna Malczewska
@en
Anna Malczewska
@nl
type
label
Anna Malczewska
@en
Anna Malczewska
@nl
prefLabel
Anna Malczewska
@en
Anna Malczewska
@nl
P31
P496
0000-0003-0321-4832